Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25502613 | 0.85 | FAAH (0.39) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL23695831 | 0.83 | FAAH (0.50) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL24673152 | 0.82 | ITGB3 (0.40) | FAAHITGB3ITGA2BEPHX2 | |
| SCHEMBL26040658 | 0.82 | DPP8 (0.36) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL23945736 | 0.81 | GNAI3 (0.45) | FAAHITGB3ITGA2BEPHX2 | |
| SCHEMBL26041045 | 0.80 | FAAH (0.37) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL26040304 | 0.79 | ITGB3 (0.34) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL25504215 | 0.78 | DPP8 (0.38) | DPP8DPP7FAAHITGB3ITGA2B | |
| SCHEMBL26040270 | 0.78 | PIK3CD (0.43) | FAAHITGB3ITGA2BEPHX2 | |
| SCHEMBL26039373 | 0.77 | MBOAT4 (0.39) | DPP8DPP7FAAHITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739076-B2 | Compound or its salt thereof targeting fibroblast activation protein, its preparation methods and its uses thereof | INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, R.O.C. (TW) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739076-B2 | Compound or its salt thereof targeting fibroblast activation protein, its preparation methods and its uses thereof | FIBP, FGFR2, FGFR1 | DPP8 1186/4885DPP7 1004/4885FAAH 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.